NCT07002736

Brief Summary

This research investigates the impact of balance training on improving functional performance and reducing fall risk in community-dwelling older adults who have recovered from COVID-19. Post-COVID-19, many elderly individuals experience lingering physical impairments, including muscle weakness, decreased coordination, and balance deficits, which increase their vulnerability to falls. The study evaluates whether a structured balance training program can enhance stability, mobility, and overall quality of life in this population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
65

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 1, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

June 2, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 4, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 20, 2025

Completed
27 days until next milestone

Study Completion

Last participant's last visit for all outcomes

October 17, 2025

Completed
Last Updated

January 6, 2026

Status Verified

June 1, 2025

Enrollment Period

4 months

First QC Date

June 1, 2025

Last Update Submit

January 5, 2026

Conditions

Keywords

older adultsBerg Balance ScaleCOVID-19Biodex

Outcome Measures

Primary Outcomes (2)

  • Biodex Balance indices

    The Biodex Stability System will be used to evaluate dynamic postural stability

    Pre and Post 12 weeks

  • Berg Balance Scale score

    The Berg Balance Scale will be used to evaluate balance capability

    Pre and Post 12 weeks

Secondary Outcomes (1)

  • Timed up and Go test

    Pre and Post 12 weeks

Study Arms (2)

The Biodex training

EXPERIMENTAL

Balance Training

Other: The Biodex trainingOther: Traditional balance training

Control

ACTIVE COMPARATOR

Traditional Balance Training

Other: Traditional balance training

Interventions

Traditional balance training only

ControlThe Biodex training

Participants will undergo balance training using the Biodex Balance System plus Traditional balance training

The Biodex training

Eligibility Criteria

Age60 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • were being older adults (aged ≥60 years), recovered from infection during the last 6 month,

You may not qualify if:

  • Individuals were excluded if they have medical history of musculoskeletal trauma or surgery, systemic disease that could affect standing or walking, visual, auditory, or cognitive impairment that preclude the ability to comprehend the instructions during conduction of the study protocol.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

BMC

Jeddah, 32143, Saudi Arabia

Location

Related Publications (1)

  • El-Bagalaty AE, Mohamed ME, Abdelraouf OR, Abdel Ghafar MA, Abdelaal AK, Abdelgalil AA, Mousa GS. Balance and Fall Risk Assessment in Community-Dwelling Older Adults after Recovery from COVID-19: A Cross-Sectional Study. Sports (Basel). 2023 Jan 28;11(2):28. doi: 10.3390/sports11020028.

    PMID: 36828313BACKGROUND

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Dr. Mariam Salem

    BMC

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 1, 2025

First Posted

June 4, 2025

Study Start

June 2, 2025

Primary Completion

September 20, 2025

Study Completion

October 17, 2025

Last Updated

January 6, 2026

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will not share

Locations